加载页面时好像出了点问题.
我们的团队已经注意到了，但如果问题仍然存在，请使用电子邮件支持小工具联系我们。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Knight Therapeutics Inc. |
| HLS Therapeutics Inc. |
| Collegium Pharmaceutical, Inc. |
| Tarsus Pharmaceuticals, Inc. |
| Amphastar Pharmaceuticals, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| KHTR.F | HLTR.F | COLL | TARS | AMPH | BHC | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 1% | -23% | 33% | -55% | 23% | 4% | ||
| Fiscal Year - 1 | -2% | -25% | 25% | -70% | 24% | 69% | ||
| Fiscal Year - 2 | -4% | -16% | -13% | -35% | 19% | 56% | ||
| Fiscal Year - 3 | 2% | -8% | 37% | -8% | 15% | -442% | ||
| Fiscal Year - 4 | 5% | -9% | 20% | NA | 0% | -70% | ||
| Fiscal Year - 5 | 2% | -12% | -25% | NA | 14% | -94% | ||
| Average | 1% | -15% | 13% | -42% | 16% | -79% | ||
| Median | 1% | -14% | 22% | -45% | 17% | -33% | ||
| Benchmarks | Ticker | |||||||
| Knight Therapeutics Inc. | OTCPK:KHTR.F | |||||||
| HLS Therapeutics Inc. | OTCPK:HLTR.F | |||||||
| Collegium Pharmaceutical, Inc. | NasdaqGS:COLL | |||||||
| Tarsus Pharmaceuticals, Inc. | NasdaqGS:TARS | |||||||
| Amphastar Pharmaceuticals, Inc. | NasdaqGS:AMPH | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | KHTR.F | HLTR.F | COLL | TARS | AMPH | BHC | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 371 | 57 | 631 | 183 | 732 | 9,625 | ||
| Fiscal Year | 371 | 57 | 631 | 183 | 732 | 9,625 | ||
| Fiscal Year - 1 | 328 | 63 | 567 | 17 | 644 | 8,757 | ||
| Fiscal Year - 2 | 294 | 61 | 464 | 26 | 499 | 8,124 | ||
| Fiscal Year - 3 | 243 | 60 | 277 | 57 | 438 | 8,434 | ||
| Fiscal Year - 4 | 200 | 56 | 310 | NA | 350 | 8,027 | ||
| Fiscal Year - 5 | 47 | 54 | 297 | NA | 322 | 8,601 | ||
| Net Income | ||||||||
| Latest Twelve Months | 4 | (20) | 69 | (116) | 160 | (46) | ||
| Fiscal Year | 4 | (20) | 69 | (116) | 160 | (46) | ||
| Fiscal Year - 1 | (17) | (28) | 48 | (136) | 138 | (592) | ||
| Fiscal Year - 2 | (30) | (24) | (25) | (62) | 91 | (225) | ||
| Fiscal Year - 3 | 16 | (13) | 72 | (14) | 62 | (948) | ||
| Fiscal Year - 4 | 42 | (15) | 27 | (27) | 1 | (560) | ||
| Fiscal Year - 5 | 15 | (20) | (23) | (5) | 49 | (1,788) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 945 | 209 | 1,143 | 265 | 1,513 | 27,350 | ||
| Latest Fiscal Quarter | 964 | 160 | 1,664 | 377 | 1,577 | 26,523 | ||
| Fiscal Year | 964 | 160 | 1,664 | 377 | 1,577 | 26,523 | ||
| Fiscal Year - 1 | 945 | 209 | 1,143 | 265 | 1,513 | 27,350 | ||
| Fiscal Year - 2 | 1,055 | 242 | 1,174 | 228 | 742 | 25,686 | ||
| Fiscal Year - 3 | 992 | 276 | 692 | 179 | 672 | 29,202 | ||
| Fiscal Year - 4 | 1,040 | 304 | 644 | 172 | 631 | 31,199 | ||
| Fiscal Year - 5 | 1,305 | 320 | 306 | 58 | 587 | 33,863 | ||
| Fiscal Year - 6 | 1,052 | 306 | 291 | 2 | 514 | 32,492 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 747 | 98 | 195 | 197 | 639 | (1,022) | ||
| Latest Fiscal Quarter | 795 | 71 | 229 | 225 | 732 | (1,279) | ||
| Fiscal Year | 795 | 71 | 229 | 225 | 732 | (1,279) | ||
| Fiscal Year - 1 | 747 | 98 | 195 | 197 | 639 | (1,022) | ||
| Fiscal Year - 2 | 826 | 125 | 195 | 193 | 529 | (692) | ||
| Fiscal Year - 3 | 842 | 161 | 203 | 167 | 446 | (106) | ||
| Fiscal Year - 4 | 886 | 169 | 186 | 166 | 402 | 535 | ||
| Fiscal Year - 5 | 811 | 178 | 87 | (6) | 381 | 1,063 | ||
| Fiscal Year - 6 | 1,030 | 158 | 92 | (1) | 332 | 2,733 | ||